Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin J Sutherland

Showing results (41-50 of 200) with videos related to

Pageof 20
Sort By:
Malaria Journal|January 24, 2016
Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan childrenJulian Muwanguzi, Gisela Henriques, Patrick Sawa, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 27, 2021
Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium speciesDonelly A van Schalkwyk, Robert W Moon, Maëlle Duffey, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 18, 2014
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaJohn Okombo, Alice W Kamau, Kevin Marsh, et al.
Parasite Epidemiology and Control|March 2, 2023
Prevalence of <i>Plasmodium falciparum</i> gametocytaemia in asymptomatic school children before and after treatment with dihydroartemisinin-piperaquine (DP)Bismarck Dinko, Dennis Awuah, Kwadwo Boampong, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 6, 2021
Antimalarial drug resistance markers in human immunodeficiency virus (HIV)-positive and HIV-negative adults with asymptomatic malaria infections in Port Harcourt, NigeriaIfeyinwa Chijioke-Nwauche, Mary C Oguike, Chijioke A Nwauche, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2007
Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxisColin J Sutherland, Thomas Haustein, Nahla Gadalla, et al.
Parasitology|August 4, 2011
Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?Colin J Sutherland, Hamza Babiker, Margaret J Mackinnon, et al.
Plos Genetics|December 31, 2020
Genetic diversity of the Plasmodium falciparum GTP-cyclohydrolase 1, dihydrofolate reductase and dihydropteroate synthetase genes reveals new insights into sulfadoxine-pyrimethamine antimalarial drug resistanceAnna Turkiewicz, Emilia Manko, Colin J Sutherland, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76Khalid Beshir, Colin J Sutherland, Ioannis Merinopoulos, et al.
Plos One|May 30, 2008
Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyteMaha Saeed, Will Roeffen, Neal Alexander, et al.
Pageof 20

Showing results (41-50 of 200) with videos related to

Sort By:
Pageof 20
Malaria Journal|January 24, 2016
Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan childrenJulian Muwanguzi, Gisela Henriques, Patrick Sawa, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 27, 2021
Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium speciesDonelly A van Schalkwyk, Robert W Moon, Maëlle Duffey, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 18, 2014
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaJohn Okombo, Alice W Kamau, Kevin Marsh, et al.
Parasite Epidemiology and Control|March 2, 2023
Prevalence of <i>Plasmodium falciparum</i> gametocytaemia in asymptomatic school children before and after treatment with dihydroartemisinin-piperaquine (DP)Bismarck Dinko, Dennis Awuah, Kwadwo Boampong, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 6, 2021
Antimalarial drug resistance markers in human immunodeficiency virus (HIV)-positive and HIV-negative adults with asymptomatic malaria infections in Port Harcourt, NigeriaIfeyinwa Chijioke-Nwauche, Mary C Oguike, Chijioke A Nwauche, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2007
Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxisColin J Sutherland, Thomas Haustein, Nahla Gadalla, et al.
Parasitology|August 4, 2011
Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?Colin J Sutherland, Hamza Babiker, Margaret J Mackinnon, et al.
Plos Genetics|December 31, 2020
Genetic diversity of the Plasmodium falciparum GTP-cyclohydrolase 1, dihydrofolate reductase and dihydropteroate synthetase genes reveals new insights into sulfadoxine-pyrimethamine antimalarial drug resistanceAnna Turkiewicz, Emilia Manko, Colin J Sutherland, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76Khalid Beshir, Colin J Sutherland, Ioannis Merinopoulos, et al.
Plos One|May 30, 2008
Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyteMaha Saeed, Will Roeffen, Neal Alexander, et al.
Pageof 20